EGF-induced expression of fused toes homolog (FTS) facilitates epithelial-mesenchymal transition and promotes cell migration in ME180 cervical cancer cells

Cancer Letters

Volumn 351, Issue 2, 2014, Pages 252-259

  Muthusami, Sridhar ^a   Prabakaran, D S ^a   Yu, Jae Ran ^b   Park, Woo Yoon ^a  

^a Chungbuk National University College of Medicine   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Cancer cell migration; EGF; EMT; FTS; MMP

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FUSED TOES HOMOLOG; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NERVE CELL ADHESION MOLECULE; REGULATOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; AKTIP PROTEIN, HUMAN; APOPTOSIS REGULATORY PROTEIN; EGFR PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA;

ARTICLE; BINDING AFFINITY; CANCER CELL; CELL MIGRATION; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FUSED TOES HOMOLOG GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR PATHOLOGY; NERVE CELL ADHESION MOLECULE GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UTERINE CERVIX CANCER; UVOMORULIN GENE; BIOSYNTHESIS; CELL MOTION; CULTURE TECHNIQUE; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; UTERINE CERVIX TUMOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS REGULATORY PROTEINS; CELL CULTURE TECHNIQUES; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 84904748242     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.06.007     Document Type: Article

References (34)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA: Cancer J. Clin. 2011, 61:69-90.
2. Harris C.P., Lu X.L., Narayan G., Singh B., Murty V.V.V.S. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chromosomes Cancer 2003, 36:233-241.
3. Scotto L., Narayan G., Nadula S.V., Arias-Pulido H., Subramaniyam S., Schneider A., et al. Identification of Copy number gain and overexpressed genes on chromosome Arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer 2008, 47:755-765.
4. Narayan G., Scotto L., Neelakantan V., Kottoor S.H., Wong A.H.Y., Loke S.L., et al. Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer. Genes Chromosomes Cancer 2009, 48:983-992.
5. Mimeault M., Batra S.K. Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies. Ann. Oncol. 2007, 18:1605-1619.
6. Shen M.R., Hsu Y.M., Hsu K.F., Chen Y.F., Tang M.J., Chou C.Y. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by avh3 integrin signaling. Carcinogenesis 2006, 27:962-971.
7. Lee M.Y., Chou C.Y., Tang M.J., Shen M.R. Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin. Cancer Res. 2008, 14:4743-4750.
8. Cano A., Perez-Moreno M.A., Rodrigo I., et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000, 2:76-83.
9. Bolos V., Peinado H., Perez-Moreno M.A., Fraga M.F., Esteller M., Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci. 2003, 116:499-511.
10. Yang J., Mani S.A., Donaher J.L., et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.
11. Martin T.A., Goyal A., Watkins G., Jiang W.G. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann. Surg. Oncol. 2005, 12:488-496.
12. Cowin P., Rowlands T.M., Hatsell S.J. Cadherins and catenins in breast cancer. Curr. Opin. Cell Biol. 2005, 17:499-508.
13. Junghans D., Haas I.G., Kemler R. Mammalian cadherins and protocadherins: about cell death, synapses and processing. Curr. Opin. Cell Biol. 2005, 17:446-452.
14. Bachelder R.E., Yoon S.O., Franci C., de Herreros A.G., Mercurio A.M. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J. Cell Biol. 2005, 168:29-33.
15. Li J., Zhou B.P. Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer 2011, 11:49.
16. Remy I., Michnick S.W. Regulation of apoptosis by the Ft1 protein, a new modulator of protein kinase B/Akt. Mol. Cell. Biol. 2004, 24:1493-1504.
17. Cinghu S., Anandharaj A., Lee H.C., Yu J.R., Park W.Y. FTS (fused toes homolog) a novel oncoprotein involved in uterine cervical carcinogenesis and a potential diagnostic marker for cervical cancer. J. Cell. Physiol. 2011, 226:1564-1572.
18. Anandharaj A., Cinghu S., Kim W.D., Yu J.R., Park W.Y. Fused Toes Homolog modulates radiation cytotoxicity in uterine cervical cancer cells. Mol. Biol. Rep. 2011, 38:5361-5370.
19. Muthusami S., Prabakaran D.S., An Z., Yu J.R., Park W.Y. EGCG suppresses Fused Toes Homolog protein through p53 in cervical cancer cells. Mol. Biol. Rep. 2013, 40:5587-5596.
20. Lee S.H., Lee K.C., Lee K.B., Shin J.W., Park C.Y., Sym S.J., Lee J.H. Radiation therapy with chemotherapy for patients with cervical cancer and supraclavicular lymph node involvement. J. Gynecol. Oncol. 2012, 23:159-167. (Erratum in: J Gynecol Oncol. 2012;23(4):293).
21. Debata P.R., Castellanos M.R., Fata J.E., Baggett S., Rajupet S., Szerszen A., Begum S., Mata A., Murty V.V., Opitz L.M., Banerjee P. A novel curcumin-based vaginal cream Vacurin selectively eliminates apposed human cervical cancer cells. Gynecol. Oncol. 2013, 129:145-153.
22. Buonato J.M., Lazzara M.J. ERK1/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition. Cancer Res. 2014, 74:309-319.
23. Ouwens D.M., de Ruiter N.D., van der Zon G.C., Carter A.P., Schouten J., van der Burgt C., Kooistra K., Bos J.L., Maassen J.A., van Dam H. Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38. EMBO J. 2002, 21:3782-3793.
24. Leslie M.C., Bar-Eli M. Regulation of gene expression in melanoma: new approaches for treatment. J. Cell. Biochem. 2005, 94:25-38.
25. Papassava P., Gorgoulis V.G., Papaevangeliou D., Vlahopoulos S., van Dam H., Zoumpourlis V. Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors. Cancer Res. 2004, 64:8573-8584.
26. Vlahopoulos S.A., Logotheti S., Mikas D., Giarika A., Gorgoulis V., Zoumpourlis V. The role of ATF-2 in oncogenesis. Bioessays 2008, 30:314-327.
27. Desai S., Laskar S., Pandey B.N. Role of ATF-2 in regulation of epithelial-mesenchymal transition and radio-sensitivity of A549 cells mediated by secreted soluble factors. J. Radiat. Res. 2014, 55:i116-i117. 10.1093/jrr/rrt162.
28. Gonzalez-Nieves R., Desantis A.I., Cutler M.L. Rsu1 contributes to regulation of cell adhesion and spreading by PINCH1-dependent and - independent mechanisms. J. Cell Commun. Signal. 2013, 7:279-293.
29. Lee J.M., Dedhar S., Kalluri R., Thompson E.W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 2006, 172:973-981.
30. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7:131-142.
31. Murakami A., Nakagawa T., Fukushima C., Torii M., Sueoka K., Nawata S., et al. Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis. Oncol. Rep. 2008, 19:99-104.
32. Ha G.H., Kim J.L., Breuer E.K. TACC3 is essential for EGF-mediated EMT in cervical cancer. PLoS One 2013, 8. 10.1371/journal.pone.0070353.
33. Tang B., Peng Z.H., Yu P.W., Yu G., Qian F. Expression and significance of Cx43 and E-cadherin in gastric cancer and metastatic lymph nodes. Med. Oncol. 2011, 28:502-508.
34. Zuo J.H., Zhu W., Li M.Y., Li X.H., Yi H., Zeng G.Q., Wan X.X., He Q.Y., Li J.H., Qu J.Q., Chen Y., Xiao Z.Q. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J. Cell. Biochem. 2011, 112:2508-2517.